Implementation of measures to prevent the spread of the Coronavirus affects both communities and businesses around the world. AroCell has so far only seen a limited effect on the company’s operations and the business continues to be continuously driven forward during this difficult period.
Our vision is to integrate precision monitoring into cancer care and help oncologists make right and timely decisions on treatments for every patient.
WELCOME TO AROCELL
AroCell AB is a Swedish in vitro diagnostics company focusing on the precision monitoring of patients suffering from hematological malignancies, breast cancer, and other solid tumors. We are developing, manufacturing and selling products for the measurement of human Thymidine Kinase 1 (TK1) concentration in blood.
